Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2022 Feb 24;139(8):1246-1250.
doi: 10.1182/blood.2021014418.

Age-related diseases of inflammation in myelodysplastic syndrome and chronic myelomonocytic leukemia

Lachelle D Weeks  1   2 , Catherine R Marinac  2   3   4 , Robert Redd  5 , Gregory Abel  3   5 , Amy Lin  2   6 , Mridul Agrawal  1 , Richard M Stone  5 , Deborah Schrag  3 , Benjamin L Ebert  1   2   7   8
Affiliations
Comparative Study

Age-related diseases of inflammation in myelodysplastic syndrome and chronic myelomonocytic leukemia

Lachelle D Weeks et al. Blood. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Prevalence of diseases of inflammaging. The prevalence of diseases of inflammaging in months −60 through −6 before diagnosis or at the pseudodiagnosis date was determined for patients with MDS/CMML, invasive solid tumor, or a representative Medicare population. Forest plots show ORs for prevalent diseases of inflammaging. (A) MDS/CMML vs representative Medicare by disease group. (B) MDS/CMML vs representative Medicare by individual diagnosis. (C) MDS/CMML vs solid tumor by disease group. Number of patients, prevalence (%), and OR (95%CI) are presented at the right of the forest plot. (D) MDS/CMML vs solid malignancy by individual diagnosis. Cardiovascular disease includes atherosclerotic heart disease, myocardial infarction (MI), cerebrovascular accident (CVA), and cardiomyopathy (heart failure); pulmonary disease includes chronic obstructive pulmonary disease (COPD), asthma, and chronic bronchitis; bone and joint diseases include a combination of osteopenia, osteoporosis, osteoarthritis, rheumatoid arthritis (RA), and gout; metabolic diseases include type 2 diabetes mellitus (T2DM), insulin resistance, fatty liver, and chronic kidney disease (CKD); and neurologic diseases include Alzheimer disease, Parkinson disease, amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), age-related macular degeneration, and non-Alzheimer dementias (other dementias). Numerical values for the ORs and 95% CIs for individual diagnoses are provided in supplemental Table 1.
See this image and copyright information in PMC

References

    1. Steensma DP, Bejar R, Jaiswal S, et al. . Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood. 2015;126(1):9-16. - PMC - PubMed
    1. Desai P, Mencia-Trinchant N, Savenkov O, et al. . Somatic mutations precede acute myeloid leukemia years before diagnosis. Nat Med. 2018;24(7):1015-1023. - PMC - PubMed
    1. Jaiswal S, Fontanillas P, Flannick J, et al. . Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014;371(26):2488-2498. - PMC - PubMed
    1. Jaiswal S, Natarajan P, Silver AJ, et al. . Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med. 2017;377(2): 111-121. - PMC - PubMed
    1. Sano S, Oshima K, Wang Y, et al. . Tet2-mediated clonal hematopoiesis accelerates heart failure through a mechanism involving the IL-1β/NLRP3 inflammasome. J Am Coll Cardiol. 2018;71(8):875-886. - PMC - PubMed

Publication types

MeSH terms